CIF Catalytic Impact Foundation

Share

PyrAmes is a digital health company focused on fundamentally transforming the delivery of health care through continuous blood pressure monitoring that is accurate, wireless and non-invasive. The comfort and ease of use of our platform has the potential to provide better blood pressure management for patients ranging from newborns to seniors. The FDA has granted Breakthrough Device Designation and 510(k) market clearance for our lead product Boppli^®. The Bosimi^® and Bosimi@Home™ platforms are currently under development and have not yet been cleared by the FDA for distribution.

Contact Us

Privacy Policy
Financial Conflict of Interest Policy

PYRAMES INC. REV CO-220

April 8, 2021

CIF Catalytic Impact Foundation

Share